Evolving pathway-driven biomarkers in breast cancer

Bibliography

• McKenna NJ, O'Malley BW. Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann NY Acad Sci 2001;949:3-5
   PubMed Web of Science ®Google Scholar
• Morley P, Whitfield JF, Vanderhyden BC, A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992;131:1305-12
   PubMed Web of Science ®Google Scholar
• Jakacka M, Ito M, Martinson F, An estrogen receptor (ER) alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 2002;16:2188-201
   PubMed Web of Science ®Google Scholar
• Guo X, Razandi M, Pedram A, Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 2005;280:19704-10
   PubMed Web of Science ®Google Scholar
• Migliaccio A, Di Domenico M, Castoria G, Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-300
   PubMed Web of Science ®Google Scholar
• Zhang Z, Kumar R, Santen RJ, The role of adapter protein Shc in estrogen non-genomic action. Steroids 2004;69:523-9
   PubMed Web of Science ®Google Scholar
• Simoncini T, Hafezi-Moghadam A, Brazil DP, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-41
   PubMed Web of Science ®Google Scholar
• Ahmad S, Singh N, Glazer RI. Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 1999;58:425-30
   PubMed Web of Science ®Google Scholar
• Lee YR, Park J, Yu HN, Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Commun 2005;336:1221-6
   PubMed Web of Science ®Google Scholar
• Planas-Silva MD, Shang Y, Donaher JL, AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 2001;61:3858-62
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Wang RA, Mazumdar A, Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem 2001;276:38272-9
   PubMed Web of Science ®Google Scholar
• Rayala SK, den Hollander P, Balasenthil S, Functional regulation of oestrogen receptor pathway by the dynein light chain 1. EMBO Rep 2005;6:538-44
   PubMed Web of Science ®Google Scholar
• Gururaj AE, Peng S, Vadlamudi RK, Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1). Mol Endocrinol 2007;21:1847-60
   PubMed Web of Science ®Google Scholar
• Mazumdar A, Wang RA, Mishra SK, Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 2001;3:30-7
   PubMed Web of Science ®Google Scholar
• Gururaj AE, Singh RR, Rayala SK, MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci USA 2006;103:6670-5
   PubMed Web of Science ®Google Scholar
• Gururaj AE, Holm C, Landberg G, Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle 2006;5:1407-10
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Balasenthil S, Broaddus RR, Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 2004;89:6130-8
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Manavathi B, Balasenthil S, Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005;65:7724-32
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Balasenthil S, Sahin AA, Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol 2005;36:670-5
   PubMed Web of Science ®Google Scholar
• Wong CW, McNally C, Nickbarg E, Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 2002;99:14783-8
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Manavathi B, Balasenthil S, Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005;65:7724-32
   PubMed Web of Science ®Google Scholar
• Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6:459-71
   PubMed Web of Science ®Google Scholar
• Balasenthil S, Sahin AA, Barnes CJ, p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 2004;279:1422-8
   PubMedGoogle Scholar
• Balasenthil S, Barnes CJ, Rayala SK, Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 2004;567:243-7
   PubMed Web of Science ®Google Scholar
• Holm C, Rayala S, Jirström K, Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst 2006;98:671-80
   PubMedGoogle Scholar
• Rayala SK, Talukder AH, Balasenthil S, P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res 2006;66:1694-701
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Li F, Barnes CJ, p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. EMBO Rep 2004;5:154-60
   PubMed Web of Science ®Google Scholar